Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

XPhyto: Is Mescaline the Next Big Mood-Modifying Medicine?

It has the potential to be the next frontier in the psychedelics renaissance, and it represents an unprecedented opportunity to innovate a notable advancement in mental health therapy. In anecdotal studies, mescaline has shown promise in treating depression, anxiety, PTSD,...
Marc Davis | April 6, 2021 |

A psychedelic renaissance

Fifty-three years after LSD was banned by the FDA, psychedelic drugs are making a comeback. Only instead of being the pills, mushrooms and acid tabs that helped college students to “turn on, tune in, drop out” Timothy Leary-style, today’...
Richard (Rick) Mills | December 3, 2019 |

Buzz on the Bullboards: T’is the Season for hot returns, or a lump of coal?

Once the U.S. Thanksgiving is in the rear-view, the mood among North American markets dramatically shifts. Traders must now juggle holidays, gifts, and vacations on one hand, and the end of their...
Jonathon Brown | December 1, 2022 |

Buzz on the Bullboards: Top stories drawing a curtain on the final week of 2022

The market mood is still cautious amid thin holiday trading. US stocks fell for a second day, and Treasury yields rose slightly.
Shoran Devi | December 29, 2022 |

Aurora Cannabis, Canopy Growth, EXMceuticals - who will be the best turnaround story?

Cannabis shares are not in demand at the moment. About a year ago the growth potential and possibilities of the rediscovered historical medicinal plant seemed to be endless. Today it is different, there is a hangover mood. The hype back then led to a buyer's market. Investors ...
Mario Hose | February 25, 2020 |

Bayer, Siltronic, XPhyto - is it worthwhile to invest now?

Tuesday began with green lights for most listed companies in Germany. The opinions of analysts and company announcements make the stock prices - or they are driven by the mood of economic data. The Ifo Business Climate Index, for example, rose by 2.2 points to 92.6 points in...
Mario Hose | August 25, 2020 |

What re-opening success or failure means for metals

“There is a Chinese curse which says ‘May he live in interesting times.’ Like it or not we live in interesting times. They are times of danger and uncertainty; but they are also more open to the creative energy of men than any other time in history.&CloseCurl...
Richard (Rick) Mills | May 22, 2020 |

Trump or Sanders? Both will pile up the debt

Whether it’s a Democrat or a Republican installed in the White House this November, you can count on fiscal discipline going out the window. Neither the incumbent, President Donald J. Trump, nor the leading Democratic contender to replace him, Bernie Sanders,...
Richard (Rick) Mills | February 26, 2020 |

Gold versus fiat

What exactly does it mean when pundits say that gold is a “store of value” and “hedge against inflation”? In this article we’re diving deep into these questions and discussing how gold has performed over tim...
Richard (Rick) Mills | May 1, 2020 |

Speculators remain skeptical of Veeco Instruments (VECO)

Since March 2009, Veeco Instruments Inc. ’s ( NASDAQ: VECO , Stock Forum ) steep ascent has been underlined by its 10-week and 20-week moving averages. These intermediate-term trendlines have contained all of VECO's weekly closes in the intervening months, ...
Elizabeth Harrow | October 28, 2012 |
1 2 3 4 5 6 7 8 9 10 ...